Fresenius sells IV manufacturing site in Chile to Medifarma as part of streamlining efforts
Fresenius SE & Co. KGaA, a global healthcare company headquartered in Germany, announced the divestment of its intravenous (IV) manufacturing site in Chile, Laboratorio Sanderson ... Read More
Zydus Lifesciences launches Mirabegron Extended-Release Tablets in US market
Zydus Lifesciences Limited has announced the launch of Mirabegron Extended-Release Tablets, 25 mg, in the US market, following the final approval from the United States ... Read More
Procter & Gamble completes game-changing acquisition of Merck’s consumer health unit
In a significant boost to its consumer health portfolio, Procter & Gamble (P&G) has concluded its €3.4 billion acquisition of German pharmaceutical giant Merck’s consumer ... Read More
Mylan launches generic hypertension drugs Benicar and Benicar HCT in US
Global pharmaceutical giant Mylan has made a significant stride in the hypertension treatment market with the US launch of the first generic versions of Daiichi ... Read More